Phage therapy program
UCSF — former BX004 phage trial site
| Status | Historical/inactive |
|---|---|
| Type | Center |
| Location | San Francisco, California; United States |
| Entry review | 2026-10-03 |
Access and enquiries
| How to enquire | Institutional trial page still offers a contact form and says accepting new patients, but its last update is July 2025. Newer SEC disclosure says the underlying BX004 program was discontinued. Do not advertise it as confirmed open. |
|---|---|
| Areas of work | Former phase 2b inhaled BX004 research for adults with CF and chronic Pseudomonas lung infection. |
| International access | No current international eligibility policy verified. |
What to confirm
- Unresolved institutional/registry status lag; same UCSF page lists National Jewish accepting and Stanford not yet accepting. No separate current general UCSF phage clinic was verified.
Related studies(1)
Study With Phage for CF Subjects With Pseudomonas Lung Infection
Conflicting status
Recorded program–study link. Website
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | ucsf-bx004 |
|---|